Group One Trading’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$257K Sell
29,800
-6,400
-18% -$69.7K ﹤0.01% 4151
2026
Q2
$453K Sell
36,200
-26,100
-42% -$350K ﹤0.01% 3732
2026
Q1
$929K Sell
62,300
-30,600
-33% -$681K ﹤0.01% 2906
2025
Q4
$2.32M Buy
+92,900
New +$1.65M ﹤0.01% 2230
2025
Q3
– Sell
-21,400
Closed -$91.2K – 9272
2025
Q2
$91.2K Buy
21,400
+2,500
+13% +$11.1K ﹤0.01% 5258
2025
Q1
$71.1K Buy
18,900
+18,800
+18,800% +$94.6K ﹤0.01% 5075
2024
Q4
$583 Sell
100
-700
-88% -$6.99K ﹤0.01% 7243
2024
Q3
$9.6K Sell
800
-7,500
-90% -$95.9K ﹤0.01% 5626
2024
Q2
$89.8K Buy
8,300
+7,100
+592% +$77K ﹤0.01% 4053
2024
Q1
$13.6K Sell
1,200
-2,100
-64% -$27.1K ﹤0.01% 5683
2023
Q4
$46.3K Buy
+3,300
New +$44.3K ﹤0.01% 5118

Other funds holding OLMA

Group One Trading's OLMA Position: Q3 2026 in Review

Group One Trading reduced its Olema Oncology (OLMA) stake by 26% in Q3 2026, selling an estimated $65.1K and leaving 16,772 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #4629.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 9 quarters since. The position peaked at $554K in Q1 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Group One Trading held 16,772 shares of Olema Oncology worth $145K as of Q3 2026.
  • Group One Trading sold 5,974 Olema Oncology shares in Q3 2026, an estimated $65.1K.
  • Olema Oncology made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4629 holding.
  • Group One Trading first reported a position in Olema Oncology in Q4 2021 and has held it in 9 quarters since.
  • Group One Trading's Olema Oncology position peaked at $554K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.